Quantitative analysis of Gamma Knife stereotactic radiosurgery for uveal melanoma

[1] Shields CL, Kaliki S, Furuta M, et al. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32(7):1363-1372.10.1097/IAE.0b013e31824d09a8Search in Google Scholar

[2] Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664-1678.10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-GSearch in Google Scholar

[3] Gunduz K, Bechrakis NE. Exoresection and endoresection for uveal melanoma. Middle East Afr J Ophthalmol. 2010;17(3):210-216.10.4103/0974-9233.65494Search in Google Scholar

[4] Virgili G, Gatta G, Ciccolallo L, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114(12):2309-2315.10.1016/j.ophtha.2007.01.032Search in Google Scholar

[5] Isager P, Osterlind A, Engholm G, Heegaard S, Lindegaard J, Overgaard J, Storm HH. Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study. Ophthalmic Epidemiol. 2005;12(4):223-232.10.1080/09286580591000836Search in Google Scholar

[6] Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:956-961.10.1016/S0161-6420(03)00078-2Search in Google Scholar

[7] Furdova A, Strmen P, Sramka M. Complications in patients with uveal melanoma after stereotactic radiosurgery and brachytherapy. Bratisl Lek Listy. 2005;106(12):401-406.Search in Google Scholar

[8] Laver NV, McLaughlin ME, Duker JS. Ocular melanoma. Archives of pathology & laboratory medicine. 2010;134(12):1778-178410.5858/2009-0441-RAR.1Search in Google Scholar

[9] Karkhaneh R, Chams H, Amoli FA, et.al. Long-term surgical outcome of posterior choroidal melanoma treated by endore section. Retina.2007;27(7):908-914.10.1097/IAE.0b013e31802fa2dbSearch in Google Scholar

[10] Dunavoelgyi R, Dieckmann K, Gleiss A et al. Local tumor control, visual acuity and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanomain 212 patients treated between 1997 and 2007. Int J Radiat Oncol Biol Phys. 2011;81(1):199-205.10.1016/j.ijrobp.2010.04.035Search in Google Scholar

[11] Desjardins L, Lumbroso-Le Rouic L, Levy-Gabriel C, et al. Treatment of uveal melanoma by accelerated proton beam. Dev Ophthalmol. 2012;49:41-57.10.1159/000328257Search in Google Scholar

[12] Marconi DG, de Castro DG, Rebouças LM, et al. Tumor control, eye preservation and visual outcomes of ruthenium plaque brachy therapy for choroidal melanoma. Brachytherapy. 2013;12(3):235-259.10.1016/j.brachy.2012.01.01222436517Search in Google Scholar

[13] Correa R, Pera J, Gómez J, et al.125I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain. Brachytherapy. 2009;8(3):290-296.10.1016/j.brachy.2009.03.18919428308Search in Google Scholar

[14] Verschueren KM, Creutzberg CL, Schalij-Delfos NE, et al. Long-term outcomes of eye-conserving treatment with ruthenium106 brachytherapy for choroidal melanoma. Radiother Oncol. 2010;95(3):332-338.10.1016/j.radonc.2010.03.02320416963Search in Google Scholar

[15] Chojniak MM, Chojniak R, NishimotoI N, et al. Primary transpupillary thermotherapy for small choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2011;249(12):1859-1865.10.1007/s00417-011-1733-621713533Search in Google Scholar

[16] Robertson DM. Melanoma endoresection: aperspective. Retina.2001;21(5):403-407.10.1097/00006982-200110000-0000111642368Search in Google Scholar

[17] Bechrakis NE, Petousis V, Willerding G et al. Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate. Br J Ophthalmol. 2010;94(4):460-466.10.1136/bjo.2009.16248719965818Search in Google Scholar

[18] Bisht RK, Kale SS, Natanasabapathi G, et al. Verification of Gamma Knife based fractionated radiosurgery with newly developed head-thorax phantom. Radiat Measur. 2016;91:65-74. doi: 10.1016/j.radmeas.2016.06.001.10.1016/j.radmeas.2016.06.001Search in Google Scholar

[19] Wilkinson DA, Kolar M, Fleming PA, Singh AD. Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (< or = 5 mm) choroidal melanoma lesions. Br J Radiol. 2008;81(970):784-789.10.1259/bjr/7681397618628320Search in Google Scholar

[20] Wackernagel W, Holl E, Tarmann L, et al. Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas. Br J Ophthalmol. 2014;98:218-223.10.1136/bjophthalmol-2013-30403124169651Search in Google Scholar

[21] Nakazawa H, Komori M, Mori Y, et al. Effect of skull contours on dose calculations in Gamma Knife Perfexion stereotactic radiosurgery. J Appl Clin Med Phys. 2014;15(2):4603. doi:10.1120/jacmp.v15i2.460310.1120/jacmp.v15i2.4603587547824710447Search in Google Scholar